American Hospital Association October 30, 2023
The Department of Health and Human Services Oct. 27 urged Merck and Pfizer to work with private insurers to maintain access to their COVID-19 oral antiviral medications as they transition from federal to commercial distribution, beginning Nov. 1. Health care providers and distributors may continue to order Merck’s Lagevrio from the federal government until Nov. 10 and Pfizer’s Paxlovid from the federal government until Dec. 15.
“Beyond these dates, all providers should ensure that they order sufficient commercial product after November 1 ahead of that transition,” HHS said in a letter to manufacturers, distributors, pharmacies and insurers. “Based on lessons learned during the transition to commercial distribution...
Today's Sponsors
Today's Sponsor